Dr. Baha Moshiree
Irritable bowel syndrome (IBS) is a condition that affects patients physically, mentally and socially. Patients who suffer from IBS and their healthcare providers are often frustrated with the lack of definitive diagnostic tools for the condition. Health care providers are seeing an increase in the number of patients who suffer from IBS and the definitive diagnosis can be challenging. This article will discuss novel diagnostic biomarkers that may be implemented in future clinical practice for patients with IBS and/or to exclude the diagnosis of patients with IBS symptomatology.
Jarvis, Mackenzie A.
"Irritable Bowel Syndrome: The Future of Diagnostic Biomarkers,"
Lynchburg Journal of Medical Science: Vol. 1
, Article 37.
Available at: https://digitalshowcase.lynchburg.edu/dmscjournal/vol1/iss3/37
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.